29
Apr
2010
Posted in I - Series B, Q - 2Q10, R - MID WEST, X - Cardiology, X - Stem Cell, XX - WI
Cellular Dynamics (Madison, WA) a commercial-stage supplier of cardiomyocytes derived from, closed a $40.6M Series B financing. Participants include Tactics II Stem Cell Ventures, Equity Group Investments and Sixth Floor Investors.